173 related articles for article (PubMed ID: 24601226)
1. Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.
Dong DG; Zhang Y; Zhang SL; Lv J; Guo EM; Fang ZZ; Cao YF
Pharmazie; 2014 Jan; 69(1):60-3. PubMed ID: 24601226
[TBL] [Abstract][Full Text] [Related]
2. In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7.
Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y
Afr Health Sci; 2014 Sep; 14(3):564-9. PubMed ID: 25352873
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms.
Teng Y; Nian H; Zhao H; Chen P; Wang G
Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345
[TBL] [Abstract][Full Text] [Related]
4. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
[TBL] [Abstract][Full Text] [Related]
5. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3).
Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ
Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550
[TBL] [Abstract][Full Text] [Related]
8. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
9. Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver.
Fu JF; Ren QY; Zhang NY; Gao B; Tu YY; Fu GQ; Li DH; Zhang YS
Pharmazie; 2012 Aug; 67(8):715-7. PubMed ID: 22957438
[TBL] [Abstract][Full Text] [Related]
10. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7.
Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J
Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512
[TBL] [Abstract][Full Text] [Related]
12. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).
Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ
Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.
Liu XY; Fang ZZ; Dong PP; Shi XH; Teng YJ; Sun XY
Pharmazie; 2012 Sep; 67(9):804-8. PubMed ID: 23016456
[TBL] [Abstract][Full Text] [Related]
14. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
Malfatti MA; Felton JS
Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
[TBL] [Abstract][Full Text] [Related]
15. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases.
Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L
Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
Aprile S; Del Grosso E; Grosa G
Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
[TBL] [Abstract][Full Text] [Related]
17. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential.
Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ
Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196
[TBL] [Abstract][Full Text] [Related]
18. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
19. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver.
Huang T; Fang ZZ; Zhang YY; Zhu LL; Feng LL; Zheng W; Cao YF; Sun DX; Yang L
Pharmazie; 2011 Mar; 66(3):212-5. PubMed ID: 21553653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
